Human melanocyte senescence and melanoma susceptibility genes.
about
XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma riskOrigins of adult pigmentation: diversity in pigment stem cell lineages and implications for pattern evolutionGenetics of melanocytic neviRole of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistanceClonal architectures and driver mutations in metastatic melanomasThe relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.Primary cutaneous melanoma: an 18-year study.Genetic and environmental melanoma models in fishAbrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.The essence of senescence.Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanomaMolecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.Pirin inhibits cellular senescence in melanocytic cells.Pharmacogenetic candidate genes for melanoma.Shared phenotypes among segmental progeroid syndromes suggest underlying pathways of aging.Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development.UV-induced skin cancer: similarities--variations.NF-kappaB activation in melanoma.The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.BRAF(E600) in benign and malignant human tumours.MAP Kinase Pathways: Molecular Roads to Primary Acral Lentiginous MelanomaBRAF kinase in melanoma development and progression.Melanomagenesis: overcoming the barrier of melanocyte senescence.The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics.The cullin7 E3 ubiquitin ligase: a novel player in growth control.Management of melanoma families.Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.Cutaneous malignant melanoma in central iran: a 20-year study.Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 function.A new era: melanoma genetics and therapeutics.Advances in melanoma senescence and potential clinical application.Oncogene-induced senescence and melanoma: where do we stand?Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease.Cellular senescence: a hitchhiker's guide.Aging of the hair follicle pigmentation system.Genetics of melanoma progression: the rise and fall of cell senescence.Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.Metastatic pathways in patients with cutaneous melanoma.Establishment and characterization of a primary and a metastatic melanoma cell line from Grey horses.
P2860
Q23909400-B55F4BB6-9923-4FC6-BE73-89436670525FQ26825328-4AB4BEC8-39C1-406A-B19A-12B246487A06Q28085036-937F1D37-86A6-4C25-8380-F80C8750064AQ28277703-FB473C3B-7DA0-449F-A63A-60062DA3A604Q28544919-1ED5FC50-F152-480C-A17C-A482DD6C9958Q33588743-C7D8351D-5F38-492A-8943-60E1E3AC3FE3Q33754062-42ADC23E-C622-4A6B-B5FD-EC1BDC53023CQ33895966-CBAA5536-1126-462B-97E8-20217E1475F8Q34253185-9208A6DA-264C-4A0C-B555-9C788A31BF67Q34288983-EDD1C245-9381-4B15-A9E0-22B3AD2CEE95Q34346745-8AD142EA-EFE7-4A64-B8A7-92E7B40A05CCQ34612281-E60395E0-9236-42B1-926D-20D21D371B20Q34803805-706D2BC5-72CB-41FD-B6FA-4E9731AFB377Q34838382-888BB99F-B14A-4B05-96FD-FDACB62D8660Q35574952-8DB1A83C-BEE0-4DFF-B878-5A787F975B2DQ36059159-B8A52C2F-54A7-4E89-A2DF-EF1397D3FDEEQ36103651-AAEC6AC7-1A9F-4136-97DD-AD70931A1AA9Q36168638-A583D253-065A-4B4D-A85B-6A812DB723E6Q36416479-00A98485-6539-401D-BD70-AF2429B56D1CQ36752192-1D5C9BEC-B3D9-4548-B291-21426A0BBA0CQ36921234-84BDEA08-D044-4972-A09C-F9A57547E93BQ36973484-557097D8-9296-4EA4-9E88-4569DCF9B2A6Q37086193-F769B865-5B1A-49EE-A80A-9367612994EBQ37182019-491F677A-8AE3-410C-815E-4D30991FF080Q37290440-ACADEC39-A4B9-4F31-88DE-CB9D9DBEC1CDQ37300974-EDFDA0F3-1214-456E-941B-64CC370048E9Q37328311-B44D21B3-2717-49D9-BE7A-CB1030565BF8Q37384015-58D49812-5C30-4763-857D-74E9D200A81AQ37569164-6E9EC29B-346A-4D76-B6E9-E1BAFD24798BQ37809859-B40AAF11-0082-40FB-909E-BBEBAF9B6035Q37815139-1CCF0037-8F83-4BFB-9777-2D74FE1BC905Q37818577-6D61401F-9CA2-497A-A9DB-5A6B3CFEF92EQ37948288-3AA970AE-BCAC-4A27-BE54-9A195B4117E8Q38244614-9507B280-DC60-4FE6-BE08-6D36472689B6Q38359181-B289F06B-558D-4B56-B54D-3DEA54853182Q38571308-0CD0FEC3-4CDA-4BC9-AA7F-B2B1CC7E888CQ38589518-16020950-798B-467C-ADFE-BA4BE8E57DF9Q39021347-11DC98CB-F1F9-4637-A43E-06D587462AC4Q39024316-EFCA354E-31A1-408C-BF1C-37A49D5A074EQ39104052-DF5A5F66-1CBA-42E5-9354-D3FB324CE262
P2860
Human melanocyte senescence and melanoma susceptibility genes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Human melanocyte senescence and melanoma susceptibility genes.
@ast
Human melanocyte senescence and melanoma susceptibility genes.
@en
type
label
Human melanocyte senescence and melanoma susceptibility genes.
@ast
Human melanocyte senescence and melanoma susceptibility genes.
@en
prefLabel
Human melanocyte senescence and melanoma susceptibility genes.
@ast
Human melanocyte senescence and melanoma susceptibility genes.
@en
P2860
P356
P1433
P1476
Human melanocyte senescence and melanoma susceptibility genes.
@en
P2093
Dorothy C Bennett
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206446
P407
P577
2003-05-01T00:00:00Z